Evidence map›Paper›PMID 22777127›Full record

ReviewNature reviews. Genetics2012

Genetic architectures of psychiatric disorders: the emerging picture and its implications.

Patrick F Sullivan, Mark J Daly, Michael O'Donovan

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 630 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
630citing papers in PubMed, 5 pooled it
80.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03742557 phase3unknown statusnot on this mapstarted 2018, after this paper: background citation

Evaluation of Schemes of Administration of Intravenous Ketamine in Treatment-resistant Depression: Clinical-neuroimaging Correlation

TypeinterventionalSponsorNational Institute of Neurology and Neurosurgery, MexicoRan2018 to 2020Enrolled30ConditionsTreatment Resistant DepressionArmsKetamine 50 MG/ML Injectable Solution, 0.5 mg/kg IV
NCT06269627 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

TypeinterventionalSponsorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Ran2025 to 2026Enrolled48ConditionsAlcohol Use DisorderArmsAcamprosate calcium, Placebo
3 · Its place in the literature

Who cites it

630 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. RICOPILI: Rapid Imputation for COnsortias PIpeLIne.Bioinformatics (Oxford, England) · 2020
    Pooled it
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

570 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Patrick F SullivanDepartments of Genetics and Psychiatry, CB# 7264, 5097 Genomic Medicine, University of North Carolina at Chapel Hill, North Carolina 27599-27264, USA. pfsulliv@med.unc.edu
Mark J Daly
Michael O'Donovan
Cardiff University · GBHarvard University · USUniversity of North Carolina at Chapel Hill · US

Funding

A Large-Scale Schizophrenia Association Study in SwedenR01MH077139 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F · 2007 to 2018
$9.9M
1/5-The Psychiatric GWAS Consortium: Integrated & Coordinated GWAS Meta-AnalysesU01MH085520 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F · 2008 to 2008
$642k
Medical Research Council G0800509Medical Research Council G0801418NIMH NIH HHS MH077139NIMH NIH HHS MH085520NIMH NIH HHS R01 MH077139NIMH NIH HHS U01 MH085520Wellcome Trust
6 · The paper itself

Abstract

Psychiatric disorders are among the most intractable enigmas in medicine. In the past 5 years, there has been unprecedented progress on the genetics of many of these conditions. In this Review, we discuss the genetics of nine cardinal psychiatric disorders (namely, Alzheimer's disease, attention-deficit hyperactivity disorder, alcohol dependence, anorexia nervosa, autism spectrum disorder, bipolar disorder, major depressive disorder, nicotine dependence and schizophrenia). Empirical approaches have yielded new hypotheses about aetiology and now provide data on the often debated genetic architectures of these conditions, which have implications for future research strategies. Further study using a balanced portfolio of methods to assess multiple forms of genetic variation is likely to yield many additional new findings.

Indexed as

AlcoholismAlzheimer DiseaseAnorexia NervosaAttention Deficit Disorder with HyperactivityBipolar DisorderChildChild Development Disorders, PervasiveHumansMajor Depressive DisorderMental DisordersModels, GeneticSchizophreniaTobacco Use Disorder

Identifiers

PMID22777127
PMCPMC4110909
OpenAlexW2017826413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.